Duloxetine HCL DR 40 MG cap 30S

Ended Awarded

Contract number
SPE2DB25FRP17
Awardee
Awarding agency
Obligated
$1,111

Award facts

Contract value 100% obligated
$1,110.54 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Duloxetine HCl DR 40 mg capsules (30-count) with a ceiling value of $1,110.54. The award was made on July 22, 2025, under a firm fixed-price delivery order contract with an ultimate completion date of July 23, 2025. This non-set-aside award represents a competitive procurement and will be performed at the vendor's Conshohocken location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare systems worldwide.

AmerisourceBergen Drug Corp is a critical federal medical supply vendor with an extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and related military healthcare programs. The company's federal contracting activity demonstrates consistent capability in fulfilling diverse medical procurement requirements through open competition, with delivery orders ranging from modest values to substantial orders. Through its prime indefinite delivery contract and associated delivery orders, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with medications spanning multiple therapeutic domains, including neurological treatments, pain management pharmaceuticals, and specialty medical supplies.

Quick answers

Who was awarded contract SPE2DB25FRP17?

SPE2DB25FRP17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.

How much is contract SPE2DB25FRP17 worth?

The government has obligated $1,111 on SPE2DB25FRP17.

Is contract SPE2DB25FRP17 an order under another contract?

Yes. SPE2DB25FRP17 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.

Was contract SPE2DB25FRP17 competed?

The extent of competition for SPE2DB25FRP17 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award